Suchergebnisse - (Person:"Wang, Ming")

PubPharm (105)

1

The target atlas for antibody-drug conjugates across solid cancers

enthalten in: Cancer gene therapy | 2024

von Fang, J. | Guo, L. | Zhang, Y. | +3

2

Efficacy and safety of ripretinib vs. sunitinib in patients with advanced gastrointestinal stromal tumor previously treated with imatinib : A phase 2, multicenter, randomized, open-label study in China

enthalten in: European journal of cancer (Oxford, England : 1990) | 2024

von Li, J. | Zhang, J. | Zhang, Y. | +33

3

DDR1/2 enhance KIT activation and imatinib resistance of primary and secondary KIT mutants in gastrointestinal stromal tumors

enthalten in: Molecular carcinogenesis | 2024

von Liu, A. | Zhang, S. | Wang, M. | +14

4

Drugs in the GIST Field (Therapeutic Targets and Clinical Trial Staging)

enthalten in: Current drug delivery | 2024

von Huang, C. | Ma, X. | Wang, M. | +1

5

SPRY4 inhibits and sensitizes the primary KIT mutants in gastrointestinal stromal tumors (GISTs) to imatinib

enthalten in: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association | 2023

von Li, S. | Zhao, S. | Liang, N. | +13

6

Children with chronic myeloid leukaemia treated with front-line imatinib have a slower molecular response and comparable survival compared with adults : a multicenter experience in Taiwan

enthalten in: British journal of cancer | 2023

von Liu, H. | Kuo, M. | Wu, K. | +15

7

Strategies to reinvigorate exhausted CD8+ T cells in tumor microenvironment

enthalten in: Frontiers in immunology | 2023

von Guan, Q. | Han, M. | Guo, Q. | +4

8

ML216-Induced BLM Helicase Inhibition Sensitizes PCa Cells to the DNA-Crosslinking Agent Cisplatin

enthalten in: Molecules (Basel, Switzerland) | 2022

von Ma, X. | Zhao, J. | Ruan, Y. | +4

9

Local Treatment of the Primary Tumor for Patients With Metastatic Cancer (PRIME-TX) : A Meta-Analysis

enthalten in: International journal of radiation oncology, biology, physics | 2022

von Ryckman, J. | Thomas, T. | Wang, M. | +12

10

Discovery of 3-pyrazolyl-substituted pyrazolo[1,5-a]pyrimidine derivatives as potent TRK inhibitors to overcome clinically acquired resistance

enthalten in: European journal of medicinal chemistry | 2022

von Gong, Y. | Wu, F. | Wang, M. | +4

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[11]